SCHEMBL24935402

SCHEMBL24935402

CC(=O)Cc1ccc(C(=O)Nc2ccc(C)cc2)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 8/20 0.71
RAB9A P51151 8/20 0.71
SMN1; SMN2 Q16637 7/20 0.60
MAPT P10636 5/20 0.60
NR1H4 Q96RI1 2/20 0.56
CCR5 P51681 2/20 0.54
MEN1 O00255 4/20 0.54
KMT2A Q03164 4/20 0.54
LMNA P02545 3/20 0.54
FFAR1 O14842 1/20 0.54
TP53 P04637 1/20 0.54
GLA P06280 1/20 0.54
NAMPT P43490 2/20 0.53
GAA P10253 1/20 0.53
KDM4E B2RXH2 1/20 0.52
MCL1 Q07820 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
ALDH1A1 P00352 2/20 0.52
CYP2C19 P33261 2/20 0.52
PTGDR2 Q9Y5Y4 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10685426 0.87 NR1H4 (0.73) NPC1RAB9ASMN1; SMN2MAPTNR1H4
SCHEMBL24935348 0.84 NPC1 (0.67) NPC1RAB9ASMN1; SMN2MAPTNR1H4
SCHEMBL5438741 0.84 RAB9A (0.67) NPC1RAB9ASMN1; SMN2MAPTNR1H4
SCHEMBL822378 0.84 RAB9A (1.00) NPC1RAB9ASMN1; SMN2MAPTMEN1
SCHEMBL27181403 0.84 RAB9A (1.00) NPC1RAB9ASMN1; SMN2MAPTMEN1
SCHEMBL12310125 0.84 RAB9A (1.00) NPC1RAB9ASMN1; SMN2MAPTMEN1
SCHEMBL14580374 0.84 RAB9A (1.00) NPC1RAB9ASMN1; SMN2MAPTMEN1
SCHEMBL15214321 0.84 RAB9A (1.00) NPC1RAB9ASMN1; SMN2MAPTMEN1
SCHEMBL24935012 0.83 SMN1; SMN2 (0.73) RAB9ASMN1; SMN2MAPTMEN1KMT2A
SCHEMBL8361567 0.83 NPC1 (0.76) NPC1RAB9ASMN1; SMN2MAPTCCR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4119546-A1 BIFUNCTIONAL COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF Suzhou Kintor Pharmaceuticals, Inc. (CN) 2023-01-18 EP disclosed